| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 7, 604-615, Copyright © 1993 by Endocrine Society
ARTICLES |
FA Kruyt, GE Folkers, AJ Walhout, BJ van der Leede and PT van der Saag
Hubrecht Laboratory, Netherlands Institute for Developmental Biology, Utrecht.
The retinoic acid (RA) receptor (RAR) beta 2 promoter is strongly activated by RA in embryonal carcinoma (EC) cells. We examined this activation in the P19 EC-derived END-2 cell line and in E1A-expressing counterparts and found strong RA-dependent RAR beta 2 promoter activation in the E1A-expressing cells, which was not observed in the parental cell line, indicating a possible role for E1A in RAR beta 2 activation. In transient transfection assays, E1A functioned as a coactivator of RA-dependent RAR beta 2 promoter activation and, moreover, was able to restore this activation in cells lacking RAR beta 2 activation. By deletion analysis, two regions in the RAR beta 2 promoter were identified that mediate the stimulatory effect of E1A: the RA response element and TATA box-containing region and a more up- stream region between -180 and -63, in which a cAMP response element- related motif was identified as a target element for E1A. In addition, determination of endogenous E1A-like activity by measuring E2A promoter activity in transient transfection assays in EC and differentiated cells revealed a correlation between RA-dependent RAR beta 2 promoter activation and the presence of this activity, suggesting an important role for the cellular equivalent of E1A in regulation of the RAR beta 2 promoter.
This article has been cited by other articles:
![]() |
B Nicke, E-O Riecken, and S Rosewicz Induction of retinoic acid receptor beta mediates growth inhibition in retinoid resistant human colon carcinoma cells Gut, July 1, 1999; 45(1): 51 - 57. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Folkers, B. van der Burg, and P. T. van der Saag Promoter Architecture, Cofactors, and Orphan Receptors Contribute to Cell-specific Activation of the Retinoic Acid Receptor beta 2 Promoter J. Biol. Chem., November 27, 1998; 273(48): 32200 - 32212. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Folkers, E. C. van Heerde, and P. T. van der Saag Activation Function 1 of Retinoic Acid Receptor beta2 Is an Acidic Activator Resembling VP16 J. Biol. Chem., October 6, 1995; 270(40): 23552 - 23559. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lotan, X.-C. Xu, S. M. Lippman, J. Y. Ro, J. S. Lee, J. J. Lee, and W. K. Hong Suppression of Retinoic Acid Receptor-{beta} in Premalignant Oral Lesions and Its Up-Regulation by Isotretinoin N. Engl. J. Med., May 25, 1995; 332(21): 1405 - 1411. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Aneskievich and E Fuchs The A/B domain of truncated retinoic acid receptors can block differentiation and promote features of malignancy J. Cell Sci., January 1, 1995; 108(1): 195 - 205. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |